Companies slapped with £35m fine for prochlorperazine price hike
Four companies have been issued with fines totalling more than £35 million by the UK's competition watchdog for entering into illegal arrangements that resulted in a 700% increase on the NHS price of prochlorperazine.
Alliance Pharmaceuticals, Focus Pharmaceuticals and the wholesaler Lexon entered into an agreement that restricted the competition for the supply of prochlorperazine 3mg dissolvable tablets to